Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;75(17):3159-3180.
doi: 10.1007/s00018-018-2854-4. Epub 2018 Jun 12.

Mechanisms of protein toxicity in neurodegenerative diseases

Affiliations
Review

Mechanisms of protein toxicity in neurodegenerative diseases

Chang Geon Chung et al. Cell Mol Life Sci. 2018 Sep.

Abstract

Protein toxicity can be defined as all the pathological changes that ensue from accumulation, mis-localization, and/or multimerization of disease-specific proteins. Most neurodegenerative diseases manifest protein toxicity as one of their key pathogenic mechanisms, the details of which remain unclear. By systematically deconstructing the nature of toxic proteins, we aim to elucidate and illuminate some of the key mechanisms of protein toxicity from which therapeutic insights may be drawn. In this review, we focus specifically on protein toxicity from the point of view of various cellular compartments such as the nucleus and the mitochondria. We also discuss the cell-to-cell propagation of toxic disease proteins that complicates the mechanistic understanding of the disease progression as well as the spatiotemporal point at which to therapeutically intervene. Finally, we discuss selective neuronal vulnerability, which still remains largely enigmatic.

Keywords: Alzheimer’s disease; Amyotrophic lateral sclerosis; Frontotemporal dementia; Huntington’s disease; Lou Gehrig’s disease; Parkinson’s disease; Polyglutamine diseases; Protein inclusions; Stress granules.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest among all the authors.

Figures

Fig. 1
Fig. 1
A schematic overview of protein toxicity. Accumulation of toxic disease proteins is shown to induce dysfunctions in specified compartments such as the nucleus, mitochondria, cytoplasm, and stress granules. They can also propagate into other nearby cells, spreading the disease pathology
Fig. 2
Fig. 2
Propagation of misfolded proteins via intercellular transmission. Gradual change in the distribution of α-synuclein (a) and tau (b) inclusions in the brains of patients suffering from Parkinson’s (a) and Alzheimer’s (b) diseases. c Intercellular transmission of misfolded proteins via exocytosis, endocytosis, exosomes, and tunneling nanotubes

References

    1. Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science. 2002;296(5575):1991–1995. doi: 10.1126/science.1067122. - DOI - PubMed
    1. Flagmeier P, Meisl G, Vendruscolo M, Knowles TP, Dobson CM, Buell AK, Galvagnion C. Mutations associated with familial Parkinson’s disease alter the initiation and amplification steps of alpha-synuclein aggregation. Proc Natl Acad Sci USA. 2016;113(37):10328–10333. doi: 10.1073/pnas.1604645113. - DOI - PMC - PubMed
    1. Hunter S, Brayne C. Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease. Mol Psychiatry. 2018;23(1):81–93. doi: 10.1038/mp.2017.218. - DOI - PubMed
    1. Neumann M. Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci. 2009;10(1):232–246. doi: 10.3390/ijms10010232. - DOI - PMC - PubMed
    1. Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, Haass C, Edbauer D. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339(6125):1335–1338. doi: 10.1126/science.1232927. - DOI - PubMed